When Ms. Floyd first learned about her breast cancer, she was pregnant. She had watched many women in her family battle cancer, but the news came as a shock as she prepared for her child’s arrival. Strong and optimistic, Ms. Floyd shares her story with a lot of generosity. She has become an advocate for…
Menopause is not only defined by the absence of menses and the appearance of hot flushes – it comes with many physical and psychological challenges that can be managed with appropriate medication. Professor Tommaso Simoncini discusses the physiological changes that occur during menopause and the social and psychological impact it can have on a woman’s…
With high blood pressure leading to almost 11 million deaths each year, affecting both high and low-income countries, awareness of the challenge of non-adherence needs to be raised among health practitioners and patients globally to improve the detection, treatment and control of hypertension. Professor Alta Schutte, Past-President of the International Society of Hypertension, highlighted that…
“Patient adherence should be acknowledged as a critical health care issue, and a multidisciplinary approach to education and management in this area should be established” says Professor John Weinman. To raise awareness on the need to better manage adherence challenges, Professor Weinman describes behavioral techniques for anticipating, preventing and detecting non-adherence. Professor Weinman’s talk also presents…
Non-adherence to treatment is often seen as a negative behavior or is associated with forgetfulness. Professor Rob Horne demonstrates that patients behave a certain way in response to a variety of parameters, including their beliefs, emotions and perceptions about their disease and treatment. There are no good or bad behaviors – there are complex behaviors.…
Depending on its intensity and the context of its occurrence, a single seizure can have profound social and medical consequences for patients and can strongly affect their quality of life. In the case of NTIs, one single dose omission can result in a seizure and lead to preventable adverse events. Detailing the costs associated with…
The progress of medicine and oncological treatments has significantly improved chances of survival for numerous types of cancer. Professor Enrique De Madaria explains how the increased efficacy of treatment associated with improvements in galenic formulations has led to a change of paradigm for cancer: from a progressive, fatal condition to a chronic disease. However, this medical success…
Cardiovascular diseases are often asymptomatic. Their “silence” is one of the contributing factors to treatment non-adherence. Based on an extensive literature review, Professor Lale Tokgözoğlu demonstrates the medical and social burden of treatment non-adherence in patients with cardiovascular diseases. Her presentation addresses the causes of non-adherence as declared by patients and non-adherence’s consequences for their…